JOHNSON CITY, N.Y. – Innovation, makers of PharmASSIST pharmacy automation solutions, today announced that MaxorPlus (Maxor) has implemented the firm’s PharmASSIST high volume pharmacy automation for its MXP mail order facility in Amarillo, Texas.
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food and Drug Administration (FDA) for colesevelam hydrochloride tablets, 625 mg, the generic version of Welchol Tablets, 625 mg, of Daiichi Sankyo Inc.
Rite Aid Corporation announced today that DisposeRx, a first-of-its-kind opioid disposal solution, is now available at all of Rite Aid’s more than 2,500 pharmacies across the United States.
Basel, SWITZERLAND – Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Aimovig (erenumab) for the preventive treatment of migraine in adults.
Millions of U.S. seniors can now take part in a Medicare program designed to prevent prediabetes from progressing to type 2 diabetes. Almost half of Americans 65 and older have prediabetes, and many don’t know it.
US WorldMeds announced that the U.S. Food and Drug Administration (FDA) approved Lucemyra (lofexidine) for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.
The U.S. Food and Drug Administration (FDA) has approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections.
Walmart on Friday reported fiscal first quarter income of $2.1 billion on a 4.4% increase in revenue, to $122.7 billion, thanks largely to a jump in online grocery sales. Walmart’s digital sales increased 33% in the quarter ended April 27.
McKesson High Volume Solutions (HVS) announced a pharmacy automation agreement with Discount Drug Mart, Inc., an Ohio-based retail drug store chain that operates more than 70 pharmacies in the state.
Albertsons Cos. and Rite Aid Corp. on Tuesday hosted a joint analyst event to discuss the strategic and financial benefits of the proposed merger transaction between the two companies.
Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis, making it the first disease-modifying therapy indicated for these patients.
NACDS today sent the following memo to chain members: We are writing to update you on President Trump’s announcement today regarding prescription drug pricing policies, and anticipated future events related to it.
CVS Health and Walgreens have commended President Trump for vowing in a speech today to fight high drug prices.
Metro Inc. has completed its $4.5 billion ($3.6 billion U.S.) acquisition of the Jean Coutu Group, creating a food and drug retailer with more than 1,300 stores in Quebec, Ontario and New Brunswick.
